Blake Schroeder, CEO of Medical Cannabis, Inc. Subsidiary Kannaway ®, Honored as Top CEO of the Year by the International Association of Top Professionals
SAN DIEGO, April 16, 2020/ PRNewswire/– Medical Marijuana, Inc.( OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that released the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that Blake Schroeder, CEO of the Company’s subsidiary Kannaway ®, was honored as the Leading CEO of the Year by the International Association of Top Professionals( IAOTP).
Schroeder was chosen for this award since of his outstanding leadership, creativity and devotion to the direct selling industry. With almost two years of expert experience in sales, marketing and worldwide business advancement, Schroeder has shown himself as an extremely qualified expert and specialist in the field.
As CEO of Kannaway ®, Schroeder’s crucial areas of expertise are global team development, taking full advantage of financial performance, multifunctional collaboration, brand name marketing, item licensing, tactical preparation and execution, communications, settlement, direct selling, rates, market growth and technique execution. Because Schroeder became CEO of Kannaway ®, the Company’s profits have grown from $ 2 million in yearly sales to nearly $70 million in yearly sales.
Inclusion in the International Association of Top Professionals is an honor in itself, however a few members in each discipline are picked for distinction. These unique honorees are identified based on their expert accomplishments, academic achievements, leadership abilities, longevity in the field, other associations and contributions to their communities.
In 2019, Schroeder got the Gold Award for the International Executive of the Year from business World Golden Bridge Awards in addition to a Silver International Stevie Award in Vienna for Executive of the Year– Healthcare Products and Services. Other awards for Schroeder in 2019 consisted of a Bronze Award for Executive of the Year– Little Business from the very best in Biz Awards and Small Business Executive of the Year in the Life Sciences, Health, Health, and Nutrition classification from Business Intelligence Group’s BIG Awards for Company.
To read more about Kannaway ®, please check out https://kannaway.com/
About Kannaway ®
Kannaway ® is a network sales and marketing business concentrating on the sales and marketing of hemp-based botanical items. Kannaway ® presently hosts weekly online sales meetings and conferences throughout the United States, using distinct insight and opportunity to sales professionals who are desirous of ending up being effective leaders in the sale and marketing of hemp-based botanical products.
About Medical Cannabis, Inc.
We are a business of firsts ® Medical Marijuana, Inc.( MJNA ) is a marijuana company with 3 unique business units in the non-psychoactive cannabinoid space: a worldwide portfolio of cannabinoid-based nutraceutical brands led by Kannaway ® and HempMeds ®; a pioneer in sourcing the first-rate legal non-psychoactive marijuana items derived from industrial hemp; and a cannabinoid-based medical research and botanical drug development sector led by its pharmaceutical investment firm and partners consisting of AXIM ® Biotechnologies, Inc and Kannalife, Inc Medical Cannabis, Inc. was called a leading CBD producer by CNBC Medical Marijuana, Inc. was also the first business to get historical import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the advancement of worldwide markets. The company’s flagship item Real Scientific Hemp Oil has actually been used in a number of successful clinical research studies throughout Mexico and Brazil to comprehend its safety and efficacy.
Medical Cannabis, Inc.’s head office remains in San Diego, California, and extra details is available at OTCMarkets.com or by checking out www.medicalmarijuanainc.com To see Medical Cannabis, Inc.’s business video, click here
Investors and customers are also motivated to buy CBD oil and other products at Medical Cannabis, Inc.’s store.
This press release may include specific positive statements and details, as defined within the meaning of Section 27 A of the Securities Act of 1933 and Area 21 E of the Securities Exchange Act of 1934, and undergoes the Safe Harbor produced by those sections. This product consists of statements about anticipated future occasions and/or monetary results that are forward-looking in nature and topic to threats and unpredictabilities. Such forward-looking declarations by meaning include dangers, uncertainties and other elements, which might cause the real outcomes, performance or accomplishments of Medical Cannabis, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been examined by the Fda. This item is not planned to diagnose, deal with, cure, or prevent any illness.
Medical Cannabis, Inc. does not sell or disperse any products that remain in offense of the United States Controlled Substances Act.
Investor Relations Contact:
P. (858) 283-4016
SOURCE Medical Cannabis, Inc.